# Axsome Therapeutics
 (stock symbol: AXSM) Logo in transparent PNG and SVG formats

## Axsome Therapeutics
 Logo large

### Axsome Therapeutics
 Logo large Download PNG (61.74 KB)

![Axsome Therapeutics
 Logo large Download PNG (61.74 KB)](/img/orig/AXSM_BIG-1275b7db.png)

### Axsome Therapeutics
 Logo large Download SVG (16.36 KB)

![Axsome Therapeutics
 Logo large Download SVG (16.36 KB)](/img/orig/AXSM_BIG-6bcda6a9.svg)

## Axsome Therapeutics
 Logo icon format

### Axsome Therapeutics
 Logo icon format Download PNG (57.24 KB)

![Axsome Therapeutics
 Logo icon format Download PNG (57.24 KB)](/img/orig/AXSM-cf0aaba0.png)

### Axsome Therapeutics
 Logo icon format Download SVG (17.11 KB)

![Axsome Therapeutics
 Logo icon format Download SVG (17.11 KB)](/img/orig/AXSM-5e82969a.svg)

## Axsome Therapeutics
 Logo large for dark backgrounds

### Axsome Therapeutics
 Logo large for dark backgrounds Download PNG (62.5 KB)

![Axsome Therapeutics
 Logo large for dark backgrounds Download PNG (62.5 KB)](/img/orig/AXSM_BIG.D-004d642c.png)

### Axsome Therapeutics
 Logo large for dark backgrounds Download SVG (16.18 KB)

![Axsome Therapeutics
 Logo large for dark backgrounds Download SVG (16.18 KB)](/img/orig/AXSM_BIG.D-ba178ea7.svg)

## Axsome Therapeutics
 Logo icon format for dark backgrounds

### Axsome Therapeutics
 Logo icon format for dark backgrounds Download PNG (59.75 KB)

![Axsome Therapeutics
 Logo icon format for dark backgrounds Download PNG (59.75 KB)](/img/orig/AXSM.D-e2324598.png)

### Axsome Therapeutics
 Logo icon format for dark backgrounds Download SVG (17.11 KB)

![Axsome Therapeutics
 Logo icon format for dark backgrounds Download SVG (17.11 KB)](/img/orig/AXSM.D-48d6d770.svg)

## About Axsome Therapeutics


Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

1. Website domain: axsome.com
2. Employees: 198
3. Marketcap: $3.11 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
